Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.
GLP-1 受體激動劑在物質使用障礙中的潛在角色:隨機試驗的系統性回顧。
Drug Alcohol Depend 2024-09-17
The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies.
藉由臨床前和臨床研究結果,探討胰高血糖素樣肽-1對患有成癮問題者的治療潛力。
Front Pharmacol 2023-04-18
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review.
糖尿病患者中胰高血糖素樣肽-1(GLP-1)受體激動劑作為預防發生抑鬱症的保護因子:系統性回顧。
J Psychiatr Res 2023-07-20
Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study.
使用 GLP-1R 激動劑 Exenatide 治療古柯鹼使用障礙的可行性:案例系列研究。
J Addict Med 2023-11-13
The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.
GLP-1 受體激動劑的抗抑鬱效應:系統性回顧與荟萃分析。
Am J Geriatr Psychiatry 2024-02-08
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.
探討 GLP-1 受體激動劑對物質使用、強迫行為和性慾的潛在影響:利用混合方法從社交媒體獲得的見解。
Brain Sci 2024-06-27
The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review.
GLP-1 受體激動劑在治療患者物質使用障礙中的療效:範疇回顧。
J Addict Med 2024-08-02